JPMorgan Downgrades Amneal Pharmaceuticals (AMRX) to Underweight
Tweet Send to a Friend
JPMorgan analyst Chris Schott downgraded Amneal Pharmaceuticals (: AMRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
